Forum
Welcome to theheart.org Forum, where discussions among healthcare providers, clinicians, and researchers reflect our common goal of decreasing cardiovascular morbidity and mortality around the world. More...
Active
Archived
Reverse order

Active threads
Stroke in Pharmacologically-Managed AF
1 1
Type 2 Diabetes: The role of genes & lifestyle
2 2
statins and cancer
1 1
Societies confront GI risks of antiplatelets, NSAIDs in consensus document
1 1
India attempts to impose world's biggest smoking ban
1 1
Questions raised about Northwestern use of valve device; prominent surgeon denies wrongdoing
1 1
CT angiography predicts mortality from coronary disease, EBT scans show
5 5
date and time please..
5 5
Updates to the STEMI Guidelines
1 1
Elective PCI possible without "safety net" of anticoagulation
4 4
FDA finds no link between statin use and ALS
1 1
Eating dark chocolate reduces CRP
1 1
Once-a-day carvedilol "noninferior" to twice-daily version in heart failure; need for it questione
3 3
Antiplatelet/anticoagulant Treatment Recommendations in the STEMI Guidelines
1 1
Detecting preDM aka IR
2 2
Pfizer to drop development of drugs for hyperlipidemia, atherosclerosis, and heart failure
14 14
The Management of Multivessel Lesions: Expert Panel Discussion
1 1
Cardiac CT better than cardiac catheterization for some
4 4
SADHART-CHF: Nurse intervention impresses for depression in heart failure, SSRI doesn't
1 1
Thyroid hormone analog fails in the treatment of heart failure
2 2
Dr Mauricio Cohen to head up cardiac cath lab at University of Miami
1 1
Improving Cardiovascular Outcomes in AF
2 2
ATHENA analysis suggests cut in stroke risk with dronedarone for atrial fib
2 2
TAPAS
4 4
Inhaled anticholinergics for COPD raise CV-event risk in meta-analysis
7 7
Live what you advocate: The exercise habits of busy cardiologists
8 8
The Prevention and Treatment of Thromboembolic Disease: A Cardiologist's Perspective
3 3
Anticoagulation in ACS... have we achieved optimal care?
2 2
Highlights from oral antiplatelet therapy for acute and chronic management of ischaemic heart dise
2 2
RV dysplasia
1 1
OASIS-5: Experts hail the trial, but some questions about details remain
1 1
Bicuspid aortic valves: Outlook good, but surveillance necessary
2 2
As to our Poll question
1 1
Groundwork laid for assays that point to MI within minutes of infarct onset
2 2
Physicians discuss concerns about device DTC advertising with US lawmakers
3 3
No increased death, MI with DES in randomized trials and registries, "mega"-meta-analysis suggests
2 2
Indian Asians with ACS present younger, have more aggressive disease
12 12
Unlocking the Code: Chromosome 9p21 and CAD risk
3 3
A to Z: Disappointing results for simvastatin 80 mg
3 3
Mortality closely tied to major bleeds at primary PCI, HORIZONS-AMI trial finds
2 2
Current trends in cardiac resynchronization therapy
3 3
COURAGE Quality of Life: How to Manage Patients With Stable Angina
6 6
US surgeon general issues "call to action" on DVT and PE
3 3
HITS pt admitted with New Onset Afib
14 14
Focus ON - Hyponatremia: Clinical challenges and unmet needs
1 1
TIME-CHF questions treatment of heart failure to natriuretic-peptide targets
1 1
New update on infective-endocarditis prophylaxis: Now a class IIa recommendation
2 2
NCEP definition of metabolic syndrome better predictor than IDF of diabetes in women
5 5
Adherence to Mediterranean diet reduces risk of major chronic diseases
11 11
PCI Latin Style
3 3
Lifestyle, not drugs, for preventing type 2 diabetes: "Gladiatorial" debate concludes
15 15
Ten years later, UKPDS shows intensive glucose lowering, but not tight BP control, reduces MI, all
5 5
Intensive BP and glucose-lowering additive in diabetics: ADVANCE
1 1
Percutaneous valve clip reduces mitral regurgitation and reverse remodeling in functional MR patie
1 1
Adding tirofiban in aspirin/clopidogrel nonresponders cuts periprocedural MI
2 2
Immunosuppression improves LV function in virus-negative inflammatory cardiomyopathy
2 2
EUROASPIRE III: Not enough being done in the treatment of high-risk primary-prevention patients
5 5
Vytorin rides out choppy SEAS
20 20
ARBs unable to TRANSCEND placebo in high-risk patients
7 7
SYNTAX: DES statistically inferior to CABG for complex coronary disease; plus CARDIA results
15 15
No benefit to intensive statin therapy in ACS patients with low baseline LDL-cholesterol levels
7 7
TRITON-TIMI 38 analysis of diabetics finds clinical gains but no bleeding cost for prasugrel vs cl
9 9
New meta-analysis of PCI vs medical therapy suggests better survival with PCI in stable CAD
6 6
Omega-3 fatty acids, but not statin therapy, cuts mortality and hospitalizations in heart failure
6 6
Welcome to the ESC 2008
14 14
US interventionalists shift to newer-generation DES despite lack of long-term evidence
4 4
Optimizing management of UA/NSTEMI: What do the new guidelines tell us?
2 2
Earlier and more aggressive LDL lowering, or better approaches for targeting high-risk individuals?
7 7
Radial-access PCI rarely performed but associated with 58% less bleeding than femoral PCI
38 38
Merck disguised Vioxx marketing as safety trial, analysis of company documents charges
17 17
Low LDL cholesterol, but not statin use, associated with an increased risk of cancer
8 8
COURAGE quality-of-life analysis: Slim early gains with PCI soon disappear
15 15
Duke Ground Round Series II Needs Assessment Survey
12 12
Children of Colorado cardiologist among victims in Oregon plane crash
3 3
Oral antiplatelet treatment strategy for ACS patients
3 3
There is a need for effective risk stratification... where do biomarkers fit in?
14 14